SJ Harper

1.2k total citations
15 papers, 943 citations indexed

About

SJ Harper is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, SJ Harper has authored 15 papers receiving a total of 943 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 5 papers in Oncology and 3 papers in Cell Biology. Recurrent topics in SJ Harper's work include Angiogenesis and VEGF in Cancer (6 papers), Hippo pathway signaling and YAP/TAZ (3 papers) and Lymphatic System and Diseases (2 papers). SJ Harper is often cited by papers focused on Angiogenesis and VEGF in Cancer (6 papers), Hippo pathway signaling and YAP/TAZ (3 papers) and Lymphatic System and Diseases (2 papers). SJ Harper collaborates with scholars based in United Kingdom, United States and South Africa. SJ Harper's co-authors include Peter W. H. Holland, John H. McVey, Brigid L.M. Hogan, David O. Bates, Ann C. Williams, Christos Paraskeva, E S Rennel, Alexander H. R. Varey, Heather S. Bevan and Yan Qiu and has published in prestigious journals such as The Journal of Cell Biology, Oncogene and The FASEB Journal.

In The Last Decade

SJ Harper

15 papers receiving 922 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
SJ Harper United Kingdom	10	565	256	176	163	102	15	943
Greg Parsonage United Kingdom	14	516 0.9×	404 1.6×	246 1.4×	90 0.6×	219 2.1×	17	1.5k
Walter Conca Saudi Arabia	16	315 0.6×	201 0.8×	123 0.7×	315 1.9×	128 1.3×	42	983
Jason R. Neil United States	11	564 1.0×	366 1.4×	105 0.6×	220 1.3×	69 0.7×	14	933
Christian Kjellman Sweden	20	463 0.8×	234 0.9×	76 0.4×	104 0.6×	73 0.7×	33	1.2k
Akihiro Nakao Japan	12	1.3k 2.3×	287 1.1×	100 0.6×	177 1.1×	57 0.6×	18	1.6k
François Blanchette Canada	10	521 0.9×	177 0.7×	62 0.4×	174 1.1×	88 0.9×	17	943
Yuka Harada Japan	23	1.0k 1.8×	203 0.8×	107 0.6×	229 1.4×	48 0.5×	106	2.0k
Gerlinde Mitterbauer Austria	27	645 1.1×	223 0.9×	268 1.5×	98 0.6×	73 0.7×	57	1.8k
Jong Seok Kang United States	9	916 1.6×	183 0.7×	83 0.5×	157 1.0×	41 0.4×	10	1.1k
Mirva Söderström Finland	18	454 0.8×	223 0.9×	158 0.9×	256 1.6×	71 0.7×	36	903

Countries citing papers authored by SJ Harper

Since Specialization

Citations

This map shows the geographic impact of SJ Harper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by SJ Harper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites SJ Harper more than expected).

Fields of papers citing papers by SJ Harper

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by SJ Harper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by SJ Harper. The network helps show where SJ Harper may publish in the future.

Co-authorship network of co-authors of SJ Harper

This figure shows the co-authorship network connecting the top 25 collaborators of SJ Harper. A scholar is included among the top collaborators of SJ Harper based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with SJ Harper. SJ Harper is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Harper, SJ, et al.. (2018). A survey of Florida citrus viruses and viroids. 5(1). 2 indexed citations

Mavrou, A, Karen Brakspear, Maryam Hamdollah‐Zadeh, et al.. (2014). Serine–arginine protein kinase 1 (SRPK1) inhibition as a potential novel targeted therapeutic strategy in prostate cancer. Oncogene. 34(33). 4311–4319. 121 indexed citations

Grigione, Melissa M., et al.. (2013). A comparative study between enteric parasites of Coyotes in a protected and suburban habitat. Urban Ecosystems. 17(1). 1–10. 21 indexed citations

Qiu, Yan, Matthew A. Seager, Heather S. Bevan, et al.. (2012). Ovarian VEGF165b expression regulates follicular development, corpus luteum function and fertility. Reproduction. 143(4). 501–511. 34 indexed citations

Salmon, Andrew, et al.. (2011). Impaired vascular permeability regulation caused by the VEGF165b splice variant in pre-eclampsia. BJOG An International Journal of Obstetrics & Gynaecology. 118(10). 1253–1261. 25 indexed citations

Woolard, Jeanette, W. D. Vousden, Stephen J. Moss, et al.. (2010). Borrelidin modulates the alternative splicing of VEGF in favour of anti-angiogenic isoforms. Chemical Science. 2(2). 273–278. 24 indexed citations

Rennel, E S, Alexander H. R. Varey, LaMonica V. Stewart, et al.. (2009). VEGF121b, a new member of the VEGFxxxb family of VEGF-A splice isoforms, inhibits neovascularisation and tumour growth in vivo. British Journal of Cancer. 101(7). 1183–1193. 43 indexed citations

Harper, SJ, et al.. (2009). Acute Endocapillary Glomerulonephritis. Bristol Research (University of Bristol). 116–119. 4 indexed citations

Varey, Alexander H. R., E S Rennel, Yan Qiu, et al.. (2008). VEGF165b, an antiangiogenic VEGF-A isoform, binds and inhibits bevacizumab treatment in experimental colorectal carcinoma: balance of pro- and antiangiogenic VEGF-A isoforms has implications for therapy. British Journal of Cancer. 98(8). 1366–1379. 174 indexed citations

10.

Harper, SJ, et al.. (2007). MP-04.12: Anti angiogenic VEGF165b is an inhibitory splice variant of VEGF in transitional cell carcinoma of the bladder. Urology. 70(3). 61–61. 1 indexed citations

11.

Woolard, Jeanette, Dawid G. Nowak, Michael Ladomery, SJ Harper, & David O. Bates. (2006). Splice factor regulation of alternative splicing of VEGF isoform families. The FASEB Journal. 20(4). 4 indexed citations

12.

Rigby, H, SJ Harper, P.S. Mortimer, et al.. (2004). Lymphatic density and metastatic spread in human malignant melanoma. British Journal of Cancer. 90(3). 693–700. 117 indexed citations

13.

Whittles, C.E., Tristan Pocock, Stephen R. Wedge, et al.. (2002). ZM323881, a Novel Inhibitor of Vascular Endothelial Growth Factor-Receptor-2 Tyrosine Kinase Activity. Microcirculation. 9(6). 513–522. 5 indexed citations

14.

Williams, Ann C., SJ Harper, & Christos Paraskeva. (1990). Neoplastic transformation of a human colonic epithelial cell line: in vitro evidence for the adenoma to carcinoma sequence.. PubMed. 50(15). 4724–30. 109 indexed citations

15.

Holland, Peter W. H., SJ Harper, John H. McVey, & Brigid L.M. Hogan. (1987). In vivo expression of mRNA for the Ca++-binding protein SPARC (osteonectin) revealed by in situ hybridization.. The Journal of Cell Biology. 105(1). 473–482. 259 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact